长效甲状腺刺激素与格雷夫斯病临床特征及病程的关系。 - Suppr

Suppr

超能文献

Relationship of long-acting thyroid stimulator to the clinical features and course of Graves' disease.

作者信息

Lipman L M, Green D E, Snyder N J, Nelson J C, Solomon D H

出版信息

Am J Med. 1967 Oct;43(4):486-98. doi: 10.1016/0002-9343(67)90175-1.

DOI:10.1016/0002-9343(67)90175-1

PMID:6072779

Abstract

摘要

相似文献

Relationship of long-acting thyroid stimulator to the clinical features and course of Graves' disease.长效甲状腺刺激素与格雷夫斯病临床特征及病程的关系。

Am J Med. 1967 Oct;43(4):486-98. doi: 10.1016/0002-9343(67)90175-1.

Relationships among immunoglobulin markers in Graves' disease.

J Clin Endocrinol Metab. 1979 Mar;48(3):381-7. doi: 10.1210/jcem-48-3-381.

Long-acting thyroid stimulator in Graves' disease.

Lancet. 1970 Aug 15;2(7668):335-8. doi: 10.1016/s0140-6736(70)92873-4.

Observations against a causal relationship between the long-acting thyroid stimulator and ophthalmopathy in Graves' disease.关于长效甲状腺刺激素与格雷夫斯病中眼病变之间因果关系的观察。

J Clin Endocrinol Metab. 1968 Aug;28(8):1177-82. doi: 10.1210/jcem-28-8-1177.

[Simultaneous determination of thyrotropic hormone and long-acting thyroid stimulator in the plasma of patients with Graves' disease].[格雷夫斯病患者血浆中促甲状腺激素和长效甲状腺刺激素的同步测定]

Klin Wochenschr. 1971 May 1;49(9):554-7. doi: 10.1007/BF01487994.

[The long acting thyroid stimulator (LATS) in some thyroid diseases. Preliminary results].[某些甲状腺疾病中的长效甲状腺刺激素（LATS）。初步结果]

Acta Isot (Padova). 1968 Oct 30;8(2):165-79.

The long-acting thyroid stimulatory: is it of importance in Graves' disease.长效甲状腺刺激素：它在格雷夫斯病中重要吗？

N Z Med J. 1975 Jan 8;81(531):18-21.

[The determination of long-acting thyroid stimulator (LATS) in thyroid diseases].[甲状腺疾病中长效甲状腺刺激素（LATS）的测定]

Wien Z Inn Med. 1968;49(4):121-30.

Graves' disease with delayed hyperthyroidism. Onset after several years of euthyroid ophthalmopathy, dermopathy, and high serum LATS.伴有迟发性甲状腺功能亢进的格雷夫斯病。在数年的甲状腺功能正常的眼病、皮肤病及高血清长效甲状腺刺激素之后发病。

Ann Intern Med. 1970 Dec;73(6):985-90. doi: 10.7326/0003-4819-73-6-985.

The long-acting thyroid stimulator and the result of I 131 treatment for thyrotoxicosis.长效甲状腺刺激素与131碘治疗甲状腺毒症的结果

Aust N Z J Med. 1972 May;2(2):168-72. doi: 10.1111/j.1445-5994.1972.tb03927.x.

引用本文的文献

Medical management of thyroid eye disease.甲状腺眼病的医学管理。

Saudi J Ophthalmol. 2011 Jan;25(1):3-13. doi: 10.1016/j.sjopt.2010.10.001. Epub 2010 Oct 26.

Clinical significance of classification of Graves' disease according to the characteristics of TSH receptor antibodies.根据促甲状腺激素受体抗体特征对格雷夫斯病进行分类的临床意义

Korean J Intern Med. 2001 Sep;16(3):187-200. doi: 10.3904/kjim.2001.16.3.187.

Orbital decompression in Graves' ophthalmopathy associated with pretibial myxedema.格雷夫斯眼病合并胫前黏液性水肿的眼眶减压术

J Endocrinol Invest. 1993 Jun;16(6):433-7. doi: 10.1007/BF03348875.

Graves' ophthalmopathy.格雷夫斯眼病

Can Med Assoc J. 1981 Apr 1;124(7):855-62, 866.

Graves' ophthalmopathy and subclinical hypothyroidism: diagnostic value of the thyrotropin releasing hormone test.格雷夫斯眼病与亚临床甲状腺功能减退症：促甲状腺激素释放激素试验的诊断价值

Can Med Assoc J. 1982 Aug 15;127(4):291-4.

Serum long acting thyroid stimulator (LATS) and LATS-protector (LATS-P) in Graves' disease associated with localized myxedema.格雷夫斯病伴局限性黏液性水肿患者血清长效甲状腺刺激素（LATS）及长效甲状腺刺激素保护物（LATS-P）

J Endocrinol Invest. 1984 Apr;7(2):151-5. doi: 10.1007/BF03348407.

Investigation of endocrine exophthalmos.内分泌性突眼症的研究。

Proc R Soc Med. 1969 Jan;62(1):13-5. doi: 10.1177/003591576906200109.

The value of IgG separation for the detection of LATS in human serum.IgG分离在检测人血清中长效甲状腺刺激素（LATS）方面的价值。

Clin Exp Immunol. 1969 May;4(5):597-601.

Acute endocrine ophthalmopathy in a 12-year-old boy with long-acting thyroid stimulator.一名12岁患有长效甲状腺刺激素的男孩的急性内分泌性眼病。

Br J Ophthalmol. 1969 Mar;53(3):203-6. doi: 10.1136/bjo.53.3.203.

Management of endocrine ophthalmopathy.内分泌性眼病的管理

Br Med J. 1968 Sep 7;3(5618):565-6.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验